Ira D. Glick, M.D., Medical Director

Ira D. Glick, M.D., Professor Emeritus of Psychiatry and Behavioral Sciences, Chief of the Schizophrenia Clinic at the Stanford University School of Medicine, has an extensive background in research, education and academic medicine. He has been a professor at three prestigious medical schools (University of California, San Francisco, Cornell and Stanford) as well as the Senior Science Advisor to the Director of the National Institute of Health (NIMH).

He is internationally recognized for his broad expertise in education, research and clinical care and as an ardent advocate for consumer organizations. As Chief of the Schizophrenia Service, he has embraced a clinical mission to provide each patient and their family with the highest quality care including cutting-edge medication, psychotherapeutic support and family intervention.

While an NIMH science advisor, he chaired the Public-Academic Liaison (PAL) Research Program. He has served on NIMH review committees and the American Psychiatric Association Committee on Research. He has been Chair of three American College of Neuropsychopharmacology committees: Education and Training, Finance as well as Constitution. He has been on the Boards of the American Society of Clinical Psychopharmacology and the American Family Therapy Academy. He is a founder and long-time Board member of both the International Society for Sport Psychiatry and the American Society of Clinical Psychopharmacology (ASCP).

Dr. Glick received his medical degree from New York Medical College in 1961. He received his Bachelor of Science degree from Dickinson College in 1957. He completed an internship at Beth Israel Hospital in New York City and residency training at Hillside Hospital in Queens, N Y and Mt. Zion Hospital in San Francisco.

He serves on numerous editorial boards, has written over 200 articles and chapters on psychiatric and academic medicine topics. He is the lead author for 1) the American Society of Clinical Psychopharmacology Model Curriculum in Psychopharmacology for psychiatric residents (now in its sixth edition), plus first editions of curriculums for medical students and for primary care physicians, 2) the standard text for marital and family therapy (now in its fourth edition) and 3) the first paper on psychiatric treatment of elite athletes as well as psychiatric aspects of basketball. He has received more than 50 NIMH, foundation and industry research grants for studies of both psychotropic medication and psychosocial treatment for psychiatric disorders.

He has negotiated and conducted international research and educational studies collaborating with investigators in a variety of countries including India, Italy, Indonesia, Japan, Uruguay, France, China and Argentina.

Dr. Glick has received numerous awards including separate (named) awards for 1) research, 2) teaching and 3) rehabilitation from the American Psychiatric Association; for research on the family model of treatment from the American Family Therapy Academy (2001); the Lundbeck International Award for the curriculum (2006); Fulbright awards for research in Japan and Italy (1987), a Fulbright lectureship in India (2005) and a Rockefeller Residency Award (2002). In 2008 he received the American College of Psychiatry’s highest award – The Distinguished Service in Psychiatry Award as well as the Association of Academic Psychiatry’s Distinguished Life Fellowship status. In 2010, he received one of the National Alliance on Mental Illness (NAMI) exemplary Psychiatrist Awards.

He has been a recipient of the yearly, “most outstanding alumnus” awards from his high school (1956), his college (2006) and his medical school (1991). He received the US Army Commendation Medal in 1966, and the Hoch Award from the American College of Neuropsychopharmacology for distinguished service to the organization (2005).